CAS number: 1187594-09-7

Baricitinib is a drug for the treatment of rheumatoid arthritis.

Our Controlled Substance and API portfolio is supported by a global network of GMP facilities: West Deptford, NJ; Devens, MA; North Andover, MA; Edinburgh, UK and Annan, UK.

Download our product list
Molecular structure of Baricitinib




Molecular weight:

 371.419 g/mol


Therapeutic area:

Treatment of rheumatoid arthritis



Please contact your Account Manager


Regulatory filings:



Manufactured in:

Please contact your Account Manager


* Monographs are available on request

† Regulatory filings are available on request

Get in touch

Send us a message to request a quote or ask our advice. We'd be happy to hear from you.

Katrina Bostardi


    Send a message

    Kevin Gwilliam

    Outside USA

      Send a message